Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Videos

Addressing the point of no return for gene therapy

Retinitis pigmentosa (RP) is hereditary retinal degenerative disease that is characterized by progressive loss of photoreceptor function. In human trials, gene therapy has been shown to improve vision; however, this benefit has not been sustainable. It is not clear if the lack of long-term benefit is due to the advanced stage of the disease at the time of therapy or due to inefficient delivery of the functional gene. In this episode, Stephen Chang and Susanne Koch discuss the development of a murine RP model that allows induction of the corrected gene at various stages of disease. The results of their study indicate that gene therapy can treat RP even at advanced stages and that future studies should focus on improving gene delivery.


Restoring the neuronal transciptome to improve cognitive decline

Epigenetic modifications, such as histone acetylation, are dysregualted in Alzheimer’s disease (AD) and other neurodegenerative disorders, resulting altered patterns of neuronal gene expression and cognitive decline. In this episode, Eva Benito-Garagorri reveals that the small molecule histone-deacetylase (HDAC) suberoylanilide hydroxamic acid (SAHA) improves cognitive function and restores neuronal gene expression patterns in murine models of aging and neurodegeneration. Importantly, oral administration of SAHA provided these beneficial effects in neurons and did not affect non-neuronal cells. The results of this study suggest that SAHA should be further explored for the treatment of neurodegenerative disorders and age-related cognitive decline.


Maintaining adult hematopoiesis

An inability to properly sustain blood cell production results in the development of hematopoietic disorders. Epigenetic regulators have been shown to be involved in the function of hematopoietic stem and progenitor cells; however, dysfunction of these enzymes is associated with development of malignancies. In this episode Stephen Nimer and colleagues identify the type II arginine methyltransferase PRMT5 as an important regulator of adult hematopoiesis. Mice lacking PRMT5 developed fatal pancytopenia due to reduced proliferation of hematopoietic progenitor cells as the results of impaired cytokine signaling and increased p53 signaling. Hematopoietic stem cell populations were not initially reduced in these animals; however, this population was unable to restore blood cell populations in lethally irradiated mice. Together, the results of this study provide important insight into the role of PRMT5-mediated gene expression in maintaining hematopoietic homeostasis.


Pinpointing epidemic group A Streptococcus strain emergence

Group A Streptococcus (GAS) causes a wide array of infections ranging from mild to serious and even life threatening.  Epidemic strains of GAS have enhanced virulence; however, the molecular events that allow for widespread dissemination of this disease are not fully understood.  In this episode, James Musser discusses the identification of genetic changes that cause increased virulence in epidemic strains of GAS. Extensive genomic sequencing of pre- and post-epidemic strains revealed the presence of SNPs within a regulatory element that increase the expression of two potent bacterial toxins. The results of this study provide insight into the molecular drivers of the emergence of epidemic GAS strains.


Stuart Kornfeld

Dr. Stuart Kornfeld is the David C. and Betty Farrell Distinguished Professor of Medicine at Washington University in St. Louis. He is best known for his work elucidating the processes governing lysosome biogenesis. His research continues to uncover roles for oligosaccharide biosynthesis, processing, and maturation in mediating proper folding and transport of proteins. In an interview with JCI Editor-at-Large Ushma Neill, Kornfeld discusses how his first biochemistry course, taught by Carl and Gerty Cori, and his work as a postdoctoral researcher in Luis Glaser’s lab led to his interest in the role of sugar moieties in cellular physiology. Kornfeld also discusses his early work with postdoctoral fellows Ira Tabas and Ajit Varki and graduate student Marc Reitman in characterizing the trafficking of lysosomal proteins. Finally, Kornfeld addresses the importance of mentors in the development of physician-scientists.

  • ← Previous
  • 1
  • 2
  • …
  • 36
  • 37
  • 38
  • …
  • 54
  • 55
  • Next →
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts